Treace Medical Concepts Q1 2025 10-Q Filed

TL;DR

**TREACE MEDICAL CONCEPTS Q1 2025 10-Q FILED: Financials updated, fair value of assets like ABS & CDs noted.**

AI Summary

Treace Medical Concepts, Inc. filed its 10-Q for the period ending March 31, 2025. The filing details financial information, including assets, liabilities, and equity, with specific mentions of fair value measurements for recurring items like asset-backed securities and certificates of deposit as of March 31, 2025. It also references prior year-end balances for prepaid expenses and additional paid-in capital.

Why It Matters

This filing provides investors with an update on Treace Medical Concepts' financial health and position as of the first quarter of 2025, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing contains standard financial disclosures for a public company, but the nature of medical device companies can involve inherent market and regulatory risks.

Key Numbers

• 2025-03-31 — Reporting Date (Financial position as of this date)
• 2024-12-31 — Prior Year End (Comparison point for financial data)
• 2023-12-31 — Previous Year End (Historical financial data reference)

Key Players & Entities

• TREACE MEDICAL CONCEPTS, INC. (company) — Filer
• 20250331 (date) — Reporting Period End Date
• 20250508 (date) — Filing Date
• 0001630627 (company) — Central Index Key
• 3841 (dollar_amount) — Standard Industrial Classification Code

FAQ

From the Filing

0000950170-25-066953.txt : 20250508 0000950170-25-066953.hdr.sgml : 20250508 20250508161024 ACCESSION NUMBER: 0000950170-25-066953 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 58 CONFORMED PERIOD OF REPORT: 20250331 FILED AS OF DATE: 20250508 DATE AS OF CHANGE: 20250508 FILER: COMPANY DATA: COMPANY CONFORMED NAME: TREACE MEDICAL CONCEPTS, INC. CENTRAL INDEX KEY: 0001630627 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 471052611 STATE OF INCORPORATION: FL FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-40355 FILM NUMBER: 25926151 BUSINESS ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 BUSINESS PHONE: (904) 373-5940 MAIL ADDRESS: STREET 1: 100 PALMETTO PARK PLACE CITY: PONTE VEDRA STATE: FL ZIP: 32081 10-Q 1 tmci-20250331.htm 10-Q 10-Q 0001630627 --12-31 Q1 false one http://www.treace.com/20250331#OperatingLeaseAndOtherLiabilities http://www.treace.com/20250331#OperatingLeaseAndOtherLiabilities http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember http://fasb.org/us-gaap/2024#SecuredOvernightFinancingRateSofrOvernightIndexSwapRateMember P2Y 0001630627 us-gaap:CommercialPaperMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001630627 us-gaap:InterestRateCapMember 2022-04-29 2022-04-29 0001630627 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001630627 us-gaap:PrepaidExpensesAndOtherCurrentAssetsMember 2024-12-31 0001630627 us-gaap:TreasuryStockCommonMember 2023-12-31 0001630627 us-gaap:FairValueInputsLevel2Member us-gaap:CertificatesOfDepositMember us-gaap:FairValueMeasurementsRecurringMember 2025-03-31 0001630627 us-gaap:AdditionalPaidInCapitalMember 2024-12-31 0001630627 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001630627 us-gaap:FairValueInputsLevel1Member us-gaap:MoneyMarketFundsMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001630627 tmci:CapitalizedSurgicalEquipmentNotReadyForUseMember 2025-03-31 0001630627 us-gaap:RetainedEarningsMember 2024-01-01 2024-03-31 0001630627 us-gaap:AdditionalPaidInCapitalMember 2023-12-31 0001630627 us-gaap:GeneralAndAdministrativeExpenseMember 2025-01-01 2025-03-31 0001630627 us-gaap:LeaseholdImprovementsMember 2024-12-31 0001630627 us-gaap:TreasuryStockCommonMember 2024-01-01 2024-03-31 0001630627 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-01-01 2024-03-31 0001630627 2022-04-29 0001630627 us-gaap:AdditionalPaidInCapitalMember 2024-03-31 0001630627 us-gaap:SalesRevenueNetMember srt:MinimumMember us-gaap:CustomerConcentrationRiskMember 2025-01-01 2025-03-31 0001630627 tmci:EarlyRepaymentYearTwoMember 2022-04-29 0001630627 us-gaap:ConstructionInProgressMember 2024-12-31 0001630627 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-03-31 0001630627 us-gaap:FairValueInputsLevel1Member us-gaap:FairValueMeasurementsRecurringMember us-gaap:USTreasuryAndGovernmentMember 2025-03-31 0001630627 us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001630627 us-gaap:RevolvingCreditFacilityMember 2022-04-29 2022-04-29 0001630627 us-gaap:PerformanceSharesMember 2025-01-01 2025-03-31 0001630627 us-gaap:CommercialPaperMember 2025-03-31 0001630627 tmci:TermLoansMember tmci:MidCapTermLoanFacilityMember 2025-03-31 0001630627 us-gaap:FairValueInputsLevel2Member us-gaap:CorporateDebtSecuritiesMember us-gaap:FairValueMeasurementsRecurringMember 2024-12-31 0001630627 us-gaap:FurnitureAndFixturesMember 2024-12-31 0001630627 us-gaap:TreasuryStockCommonMember 2024-03-31 0001630627 us-gaap:CorporateDebtSecuritiesMember 2024-01-01 2024-12-31 0001630627 us-gaap:CommonStockMember 2024-01-01 2024-03-31 0001630627 us-gaap:MoneyMarketFundsMember us-gaap:FairValueInputsLevel1Member us-g